Cognitive performance products Marylebone: what works

Evidence-based guide to cognitive performance supplements in Marylebone, what the RCT data supports, what it doesn't, and how cardiovascular health drives brain output.

From this read

If you're based in or around Marylebone and looking for cognitive performance products that are actually backed by evidence, the honest answer is: the list is shorter than the market suggests. Cardiovascular health and cognitive output are tightly linked, cerebral blood flow, oxidative load, and mitochondrial function all sit at that intersection. One 2021 analysis estimated that cognitive impairment costs the global economy trillions annually, which tells you how seriously this deserves to be taken. Smith et al. (2021)

What the evidence actually shows

The cognitive performance supplement market is enormous and largely unregulated in terms of marketing claims. Most products lean on mechanism-level biology, "this compound is found in the brain", and hope you don't ask for the RCT data. I did ask. The picture is more nuanced than either the sceptics or the sellers admit.

Presenteeism, showing up but functioning below capacity, is a measurable economic and personal problem. Brooks et al. (2011) identified cognitive impairment as one of the primary drivers of presenteeism in working populations, distinct from physical illness. The implication: optimising cognitive output isn't vanity. It's practical.

What the literature consistently supports is that cardiovascular-adjacent interventions, things that affect blood pressure, endothelial function, and cerebral perfusion, tend to have the most reproducible effects on cognitive metrics. Clark et al. (2017) found that cognitive dysfunction and reduced work productivity are closely correlated, and that the pathway often runs through physiological rather than purely psychological mechanisms. That framing matters when you're choosing what to take.

There's also a broader argument for thinking about "brain capital", the aggregate of cognitive and emotional resources a person brings to their work and life. Smith et al. (2021) make the case that investing in this systematically, rather than reactively, is the more rational approach. I agree with that framing. It's why I built KōJō around daily consistency rather than acute dosing spikes.

---

The cardiovascular-cognitive link: what's biologically happening

The brain consumes roughly 20% of the body's oxygen despite being about 2% of body weight. That makes it extraordinarily sensitive to anything affecting vascular function. Reduced endothelial nitric oxide availability, elevated oxidative stress, and impaired microvascular perfusion all translate, over time, into measurable cognitive decline, slower processing speed, reduced working memory capacity, diminished executive function.

The pathway works like this. Oxidative stress damages the endothelial lining of blood vessels. That damages nitric oxide synthase activity. Reduced NO availability causes vasoconstriction and impairs blood flow regulation. In the brain, this manifests as reduced cerebral perfusion, particularly in the prefrontal cortex, which handles the kind of focused, analytical work most knowledge workers in Marylebone are paid to do.

Several plant-derived polyphenols, including those found in grape seed, pine bark, and olive leaf, appear to support endothelial function through antioxidant pathways, though the human data on each varies considerably in quality and scale. Vitamin C contributes to the protection of cells from oxidative stress [GB-NHC], which places it at the mechanistic centre of this story. At 500 mg per day, it's one of the more evidence-anchored interventions available.

Separately, creatine's role in cognitive performance is increasingly discussed. The mechanism here is different, creatine replenishes phosphocreatine stores in neurons, supporting ATP resynthesis during high-demand cognitive tasks. The brain, like muscle, can become energetically limited during sustained effort. This is a plausible mechanism, though I'd be overstating it to claim the cognitive evidence for creatine is as strong as the physical performance data.

---

Dosing: what the clinical evidence supports

Dose matters more than most product labels suggest. A compound that shows effects at 600 mg in a clinical trial probably won't do much at 60 mg, regardless of what the marketing says. Here's my honest read of where the dose-response data is credible.

Creatine monohydrate

The physical performance evidence is solid. Creatine increases physical performance in successive bursts of short-term, high intensity exercise [GB-NHC]. The standard loading-free maintenance dose in the literature is 3, 5 g daily. The KōJō Daily Formula delivers 5,000 mg of micronised creatine monohydrate, the upper end of the evidence-supported range, in the form with the best absorption data.

Vitamin C

Vitamin C contributes to normal energy-yielding metabolism and to the reduction of tiredness and fatigue [GB-NHC]. The authorised threshold for these claims is 12 mg/day. At 500 mg, the formula delivers well above that. Vitamin C also contributes to the protection of cells from oxidative stress [GB-NHC], which is directly relevant to the cardiovascular-cognitive pathway described above.

Polyphenol compounds

Aged garlic extract, olive leaf extract, grape seed extract, and pine bark extract each have research programmes behind them, but large-scale, long-duration RCTs in healthy adults are limited for all four. I'll cover each honestly below. The doses in the formula, 600 mg aged garlic, 500 mg olive leaf, 200 mg grape seed, 150 mg pine bark, are broadly in line with the ranges used in smaller published trials, but I won't overstate what that means given the evidence base.

---

The polyphenol stack: honest ingredient-by-ingredient assessment

Aged garlic extract

The research on aged garlic extract benefits is more developed than most people realise, particularly in the cardiovascular space. Several small-to-medium RCTs suggest it may support blood pressure and arterial stiffness markers, though large-scale human trials are still limited and the field is ongoing. The proposed mechanism involves S-allylcysteine and other organosulphur compounds acting on nitric oxide pathways.

Olive leaf extract

Oleuropein, the primary active compound, has been studied for its effects on endothelial function and blood pressure. Some evidence suggests it may influence lipid oxidation markers, though the human data is thin and I'd be overstating it to claim definitive cardiovascular effects from current trial data alone. Research is ongoing.

Grape seed extract

Proanthocyanidins from grape seed may support vascular tone through antioxidant activity at the endothelial level. Some studies suggest a modest effect on systolic blood pressure in hypertensive individuals, but large-scale confirmatory trials are limited and results across studies are inconsistent. I find the mechanistic case more convincing than the clinical evidence currently warrants.

Pine bark extract

Pine bark extract (often studied as Pycnogenol) has a reasonable body of small trial data on endothelial function and platelet aggregation. Some evidence suggests it may support cognitive metrics in specific populations, older adults, students under exam pressure, though the human data on this is thin for healthy working-age adults and I'd be overstating it to claim otherwise. Research is ongoing.

---

Cognitive style, deep work, and the sedentary office problem

There's a context problem that supplements can't solve on their own. Bhargava (2017) make the case that sustained, focused cognitive work, what Cal Newport calls "deep work", is increasingly rare and increasingly valuable. But the modern office environment actively works against it: constant notifications, open-plan noise, back-to-back meetings.

Physical environment matters too. Torbeyns et al. (2015) found that sedentary behaviour at desk-based workstations is associated with reduced cognitive performance metrics, and that introducing light movement, even standing, during work periods may support output. That's not a supplement story. It's a behaviour story. But it interacts with the cardiovascular-cognitive pathway I described earlier: sedentary behaviour worsens endothelial function, which worsens cerebral perfusion, which worsens cognitive output.

Cognitive style versatility also appears relevant. Aggarwal et al. (2023) found that individuals who can shift between analytical and intuitive cognitive modes show better collaborative outcomes, suggesting that cognitive performance isn't just about raw processing speed, but flexibility. That's a harder thing to supplement for. But the evidence base for "cognitive performance" is broader and more nuanced than most product pages suggest.

Sleep is the other variable that dwarfs most supplement effects. If you're sleeping poorly, almost nothing in a capsule will compensate. I've written about this in more depth in the context of a natural sleep supplement UK piece, worth reading alongside this one if sleep quality is part of your picture.

---

The cardiovascular case for DHA and omega-3

Algal DHA sits at the intersection of cardiovascular and cognitive health more directly than most ingredients. DHA is the primary structural fatty acid in neuronal membranes. Cerebral blood flow, neuronal signalling efficiency, and inflammatory regulation in the brain all have documented relationships with DHA status.

The cardiovascular case is also meaningful. I've covered the dose-response data in detail in the piece on omega 3 at 40 the cardiovascular and cognitive case, if you're over 35 and thinking about cognitive performance products, that article is probably the most useful thing I've written on the topic.

The algal source matters for two reasons: it's the original source (fish accumulate DHA by eating algae), and it avoids the sustainability and heavy metal concerns associated with fish oil. For anyone in Marylebone looking at cognitive performance products with a cardiovascular rationale, DHA is probably the ingredient with the strongest combined evidence base across both categories.

---

What "transparency" actually means when buying supplements in London

I started KōJō partly because I was frustrated by what I found when I looked closely at supplement labels in London, and Marylebone's health food and pharmacy scene is no exception. Proprietary blends that hide individual ingredient doses. Marketing language that implies clinical evidence where none exists. Ingredients dosed at a fraction of what the studies used.

The things I look for when evaluating any cognitive performance product:

• Are individual ingredient doses listed? If not, walk away.
• Do those doses match the ranges used in the cited studies?
• Are the claims regulatory-compliant, or are they implying effects that haven't been authorised?
• Is the form of the ingredient the one studied? Research suggests the form matters considerably, creatine monohydrate and creatine HCl have different absorption profiles; ubiquinol and ubiquinone have different bioavailability data. Check which form was used in the trial the label is gesturing at.
• Is there a plausible mechanism, or just a vague "supports brain health" line?

Messeri et al. (2024) wrote compellingly about how AI-generated content is creating illusions of understanding in scientific research, people reading confident summaries and assuming they've understood the primary evidence. The same dynamic plays out in supplement marketing. A confident label doesn't mean confident evidence. Mueller et al. (2015) showed something adjacent: that encoding information at a surface level, without deep processing, produces weaker understanding. Reading a supplement label is not the same as reading the study it's gesturing at.

---

Frequently asked questions

---

My honest take

I live and work close enough to Marylebone to know the kind of person who searches for cognitive performance products there. High-functioning, time-poor, sceptical enough to want evidence but busy enough to want someone to have done the reading first. I built KōJō for that person, and I've tried to be the version of that person who actually reads the studies rather than the abstracts.

What I've concluded, after several years of doing this: the cardiovascular-cognitive link is real and underappreciated. Most people thinking about cognitive performance are focused on the brain in isolation, nootropics, adaptogens, whatever's trending. The more durable interventions tend to work through vascular and metabolic pathways. That's less exciting to market. It's more honest to say.

The ingredients I'm most confident in, for this specific goal, are vitamin C (for oxidative stress protection, at doses that actually matter), creatine (for the physical performance evidence and the plausible cognitive mechanism), and DHA (for the structural neuronal case and the cardiovascular overlap). The polyphenol compounds, aged garlic, olive leaf, grape seed, pine bark, have research programmes I find genuinely interesting, but I won't pretend the large-scale human trial data is there yet. It isn't.

What I'm least confident in is the idea that any single product solves this. Bhargava (2017) are right that deep, focused cognitive work requires structural conditions, time, environment, reduced interruption, that no supplement creates. And Aggarwal et al. (2023) remind me that cognitive performance isn't just about intensity but flexibility, the ability to shift modes, collaborate, think differently. That's a harder thing to put in a formula.

I'm also conscious, as Logigian (1988) noted in early productivity analysis, that measuring cognitive output is genuinely hard, which means the supplement industry has always had room to make claims that are difficult to falsify. My response to that isn't to oversell. It's to be specific about what the evidence says and where it runs out.

If you're in Marylebone looking for cognitive performance products, start with the cardiovascular foundations. Sleep, movement, vascular health. Then build from there with ingredients that have dose-matched evidence. That's the less glamorous answer. I think it's the right one.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.

References (10 studies)

1. Smith et al. (2021), A Brain Capital Grand Strategy: toward economic reimagination. PMID 33100330.
2. Brooks et al. (2011), Presenteeism: critical issues. PMID 21063183.
3. Clark et al. (2017), Cognitive dysfunction and work productivity in major depressive disorder. PMID 27268275.
4. Bhargava (2017), Deep Work: A Productivity Superpower. PMID 27986095.
5. Torbeyns et al. (2015), Active workstations to fight sedentary behaviour. PMID 24842828.
6. Messeri et al. (2024), Artificial intelligence and illusions of understanding in scientific research. PMID 38448693.
7. Mueller et al. (2015), The pen is mightier than the keyboard: advantages of longhand over laptop note taking. PMID 24760141.
8. Aggarwal et al. (2023), The benefits of cognitive style versatility for collaborative work. PMID 35901407.
9. Logigian (1988), Productivity analysis. PMID 3688141.
10. Kakkar (2016), Patent cliff mitigation strategies: giving new life to blockbusters. PMID 26372691.

Photo via Unsplash